144 related articles for article (PubMed ID: 1627381)
1. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
Losi L; Benhattar J; Costa J
Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
[TBL] [Abstract][Full Text] [Related]
2. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
4. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa.
Zhang H; Nordenskjöld B; Dufmats M; Söderkvist P; Sun XF
Eur J Cancer; 1998 Dec; 34(13):2053-7. PubMed ID: 10070310
[TBL] [Abstract][Full Text] [Related]
6. K-ras mutations in patients with early colorectal cancers.
Andreyev HJ; Tilsed JV; Cunningham D; Sampson SA; Norman AR; Schneider HJ; Clarke PA
Gut; 1997 Sep; 41(3):323-9. PubMed ID: 9378386
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
8. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
9. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation.
Caruso MG; Notarnicola M; Bifulco M; Laezza C; Guerra V; Altomare DF; Memeo V; Lorusso D; Demma I; Di Leo A
Scand J Gastroenterol; 2003 Jan; 38(1):80-5. PubMed ID: 12608469
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease.
Borchers R; Heinzlmann M; Zahn R; Witter K; Martin K; Loeschke K; Folwaczny C
Scand J Gastroenterol; 2002 Jun; 37(6):715-8. PubMed ID: 12126252
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
12. Detection of tumour DNA in serum of colorectal cancer patients.
de Kok JB; van Solinge WW; Ruers TJ; Roelofs RW; van Muijen GN; Willems JL; Swinkels DW
Scand J Clin Lab Invest; 1997 Nov; 57(7):601-4. PubMed ID: 9397491
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations and prognosis in large-bowel carcinomas.
Andersen SN; Løvig T; Breivik J; Lund E; Gaudernack G; Meling GI; Rognum TO
Scand J Gastroenterol; 1997 Jan; 32(1):62-9. PubMed ID: 9018769
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
[TBL] [Abstract][Full Text] [Related]
15. High incidence of ras gene mutation in intrahepatic cholangiocarcinoma.
Tada M; Omata M; Ohto M
Cancer; 1992 Mar; 69(5):1115-8. PubMed ID: 1739910
[TBL] [Abstract][Full Text] [Related]
16. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.
Tobi M; Luo FC; Ronai Z
J Natl Cancer Inst; 1994 Jul; 86(13):1007-10. PubMed ID: 8007010
[TBL] [Abstract][Full Text] [Related]
18. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
19. Ras oncogene activation in benign and malignant colorectal tumours.
Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
[TBL] [Abstract][Full Text] [Related]
20. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
